Flipping the switch: integrin switching provides metastatic competence
Aasakiran Madamanchi1, Andries Zijlstra, Mary M Zutter
1Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN.
Abstract:
Integrin switching plays a critical role in the progression to metastatic disease, but the mechanism by which it contributes remains poorly understood. In the 11 February 2014 issue of Science Signaling, Truong et al. identified a transforming growth factor-β-mediated, prometastatic switch that is activated by β1 integrin inhibition in triple-negative breast cancers (TNBCs). Their work provides insight into the complex signaling changes that arise from integrin switching. Further characterization of β-integrin switching will require elucidation of the distribution of specific α-β integrin heterodimers and the role of ligand binding. Identifying the nature of the molecular interactions and the influence of a specific oncogenic context, including the status of driver mutations such as those in Myc and p53, will define the next phase in integrin cancer biology.
Insights
Integrin switching in triple-negative breast cancer (TNBC) activates a prometastatic pathway. This study identifies transforming growth factor-β as a key mediator, offering new insights into cancer metastasis.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Integrin switching is crucial for cancer metastasis but its mechanisms are unclear.
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options.
Purpose of the Study:
- To investigate the role of integrin switching in TNBC progression.
- To identify molecular mechanisms driving prometastatic signaling in TNBC.
Main Methods:
- Analysis of transforming growth factor-β signaling pathways.
- Investigating the impact of β1 integrin inhibition on cancer cells.
Main Results:
- A transforming growth factor-β-mediated prometastatic switch activated by β1 integrin inhibition was identified in TNBC.
- The study provides insights into complex signaling changes resulting from integrin switching.
Conclusions:
- Understanding integrin switching is vital for deciphering TNBC metastasis.
- Future research should focus on specific integrin heterodimers, ligand binding, and oncogenic context.
Related Concept Videos
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Intracellular Signaling Affects Focal Adhesions
Some...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Cancer Cell Migration through Invadopodia
Selectins


